1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Success: Bufferin Premium

Success: Bufferin Premium

  • February 2015
  • -
  • GlobalData
  • -
  • 18 pages

Summary
Brands can significantly benefit from developing an in-depth understanding of the reasons for the success and failure of new product launches or marketing campaigns. This case study outlines how Lion Corporation adapted a premium branding that is currently popular in the food and drink sector in Japan into OTC medicine.


Synopsis
- Use Canadean Consumer's selection of successful and failed product launches and marketing campaigns from across the globe to inspire innovation.

- Reduce the risk of failure by learning from brands/products that have under-performed: failed innovation can severely impact profit and reputation.

- Understand the relevant consumer trends and attitudes that drive and support innovation success.

- Obtain a broader appreciation of the fast-moving consumer goods industry by gaining insights from both within and outside of your sector.

Reasons To Buy
- Why is Bufferin Premium considered an interesting case of success?

- What consumer insight underpins this success?

- Which consumer trends have these product innovations capitalized on?

- What can I learn from the success of Bufferin Premium?

Key Highlights
Bufferin Premium is the latest and top end antipyretic analgesic variety from the long-established Bufferin brand, which mainly appeals to female consumers in their 30s.

"Premium" was a keyword of the food and drink sector in Japan during 2014, particularly after a tax increase in April; Lion has captured this rising trend and used it for an OTC product.

Table Of Contents

Success: Bufferin Premium

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global OTC Analgesics Market - Growth, Trends and Forecast (2017 - 2022)

Global OTC Analgesics Market - Growth, Trends and Forecast (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The global OTC Analgesics market accounted for a market value of USD XX billion in 2015. The market is expected to reach USD XX billion in 2016 and USD XX billion by 2021, growing at a CAGR of xx% during ...

Pain Management - Medical Devices Pipeline Assessment, 2016

Pain Management - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by GlobalData

Pain Management - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Pain Management - Medical Devices Pipeline Assessment, 2016" provides an overview of Pain ...

Dental Pain Global Clinical Trials Review, H2, 2016

Dental Pain Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Dental Pain Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Dental Pain Global Clinical Trials Review, H2, 2016" provides an overview of Dental Pain clinical trials ...

The Generic Injectables Market

February 2017 $ 3850

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.